FDA says pharma employee destroyed records at troubled plant; EQRX is sold for cash

Taking stock of the drug industry, from the lab to the medicine chest

August 1, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Manuel Balce Ceneta/AP STAT+ | Intas Pharma employee used acid to destroy manufacturing records at troubled plant Intas officials did not investigate one episode in which documents were destroyed and the impact on the quality of its drugs for six days. By Ed Silverman STAT+ | EQRx, failed developer of low-priced cancer drugs, is sold for cash The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution, according to terms. By Adam Feuerstein STAT+ | Private equity-owned physician groups plan lobbying push on mergers The Welsh Carson physician groups' hiring of lobbyists coincides with federal antitrust officials and lawmakers circling their businesses. By Bob Herman Jim Mone/AP STAT+ | Labor Department says UnitedHealth Group unit illegally denied emergency room, drug screen claims The Labor Department says in a lawsuit that UnitedHealth Group unit illegally denied claims for emergency room care and drug screens. By Tara Bannow Cannabis industry scales back its lobbying in Washington Congress hasn't yet legalized weed, but it's a popular idea. So why is the industry pulling its lobbyists out of Washington? By Nicholas Florko

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser